Interestingly, a model of Dnmt3a-driven CHIP demonstrated that acquiring Npm1 mutations can lead to the development of myeloproliferative disorders (MPD), and additional transplantation leads to AML (SanMiguel et al., 2022). The gene discussed is STUB1; the disease is acute myeloid leukemia.